good news and bad news about Vioxx

May 2002

The good news and bad news about Vioxx is creating questions.

Rheumatoid arthritis. Vioxx (rofecoxib) is now approved for symptoms of rheumatoid arthritis in adults... 25 mg once a day.

GI safety. The FDA now allows Merck to say that Vioxx reduces the risk of GI bleeding and perforations 50% compared to naproxen.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote